Cleared Traditional

K962402 - AMO PRESTIGE DAY PACK (ALLERGAN, INC.)

K962402 is an FDA 510(k) clearance for AMO PRESTIGE DAY PACK (ALLERGAN, manufactured by Allergan, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1996
Decision
90d
Days
Class 2
Risk

K962402 is an FDA 510(k) clearance for the AMO PRESTIGE DAY PACK (ALLERGAN, INC.). Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Allergan, Inc. (Irvine, US). The FDA issued a Cleared decision on September 19, 1996 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Allergan, Inc. devices

FDA 510(k) Submission Details - K962402

510(k) Number K962402 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 1996
Decision Date September 19, 1996
Days to Decision 90 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 110d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 194
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K962402.
HANDPIECE FOR NIDEK CV-12000 PHACO SYSTEM
K960287 · Nidek, Inc. · Nov 1996
PHACOSCOPE
K960811 · Saint John'S Plaza Medical Group · Oct 1996
STORZ D7120 PHACO HANDPIECE MAINTENANCE KIT & STORZ D7125 PHACO HANDPIECE NEEDLE WRENCH
K960024 · Storz Instrument Co. · Sep 1996
STORZ D7116 MICROVIT VITRECTOMY CUTTER EXTENSION
K960003 · Storz Instrument Co. · Aug 1996
STORZ D4600 AIR EXCHANGE LINE PACK
K962131 · Storz Instrument Co. · Aug 1996
STORZ DP5200 IRRIGATION ADDMINISTRATION SET PACK
K961831 · Storz Instrument Co. · Aug 1996